Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world.
Roth
B J
BJ
Department of Medicine, Indiana University Medical Center, Indianapolis.
Bajorin
D F
DF
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D005708:Gallium / Q000627:therapeutic use; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D016597:Trimetrexate / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D011743:Pyrimidines; D003841:Deoxycytidine; D014747:Vinblastine; D004317:Doxorubicin; D005708:Gallium; C024530:piritrexim; D017239:Paclitaxel; D002945:Cisplatin; D007069:Ifosfamide; D016597:Trimetrexate; C027235:gallium nitrate; D008727:Methotrexate; D000093542:Gemcitabine